Cutaneous neoplasms of uncertain differentiation

Published:October 29, 2021DOI:https://doi.org/10.1016/j.mpdhp.2021.10.006

      Abstract

      Tumours of uncertain differentiation represent a markedly heterogeneous group of neoplasms that show no identifiable line of differentiation by currently available technologies, and do not resemble any specific normal cells or tissues. Continuing advances in molecular genetics have significantly aided to our understanding of these tumours, enabling refinements in classification and better insights into their biology, and furthering the development of ancillary immunohistochemical and molecular diagnostic tests and targeted therapies in the clinical setting. This review summarizes key genetic, morphologic and immunohistochemical features for a selection of cutaneous neoplasms of uncertain differentiation, with emphasis on new entities and developments in the diagnostic setting.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Diagnostic Histopathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Miller K.
        • Goodlad J.R.
        • Brenn T.
        Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
        Am J Surg Pathol. 2012; 36: 1317-1326
        • Beer T.W.
        • Drury P.
        • Heenan P.J.
        Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
        Am J Dermatopathol. 2010; 32: 533-540
        • Luzar B.
        • Calonje E.
        Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review.
        J Cutan Pathol. 2010; 37: 301-309
        • Wieland C.N.
        • Dyck R.
        • Weenig R.H.
        • Comfere N.I.
        The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
        J Cutan Pathol. 2011; 38: 884-888
        • Dei Tos A.P.
        • Maestro R.
        • Doglioni C.
        • et al.
        Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
        Am J Pathol. 1994; 145: 11-17
        • Griewank K.G.
        • Schilling B.
        • Murali R.
        • et al.
        TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
        Mod Pathol. 2014; 27: 502-508
        • Koelsche C.
        • Stichel D.
        • Griewank K.G.
        • et al.
        Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
        Clin Sarcoma Res. 2019; 9: 2
        • Carter J.M.
        • Weiss S.W.
        • Linos K.
        • DiCaudo D.J.
        • Folpe A.L.
        Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy.
        Mod Pathol. 2014; 27: 294-302
        • Lao I.W.
        • Yu L.
        • Wang J.
        Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series.
        Histopathology. 2017; 70: 394-401
        • Perret R.
        • Michal M.
        • Carr R.A.
        • et al.
        Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
        Histopathology. 2021; 79: 810-825
        • Hofvander J.
        • Tayebwa J.
        • Nilsson J.
        • et al.
        Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
        Clin Cancer Res. 2015; 21: 864-869
        • Hallor K.H.
        • Sciot R.
        • Staaf J.
        • et al.
        Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
        J Pathol. 2009; 217: 716-727
        • Kao Y.C.
        • Ranucci V.
        • Zhang L.
        • et al.
        Recurrent BRAF gene rearrangements in myxoinflammatory fibroblastic sarcomas, but not hemosiderotic fibrolipomatous tumors.
        Am J Surg Pathol. 2017; 41: 1456-1465
        • Antonescu C.R.
        • Suurmeijer A.J.
        EWSR1-SMAD3-positive fibroblastic tumour (emerging).
        in: WHO Classification of Tumours Editorial Board World Health Organization classification of soft tissue and bone tumours. 5th ed. IARC Press, Lyon2020
        • Kao Y.C.
        • Flucke U.
        • Eijkelenboom A.
        • et al.
        Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms.
        Am J Surg Pathol. 2018; 42: 522-528
        • Enzinger F.M.
        Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm.
        Cancer. 1979; 44: 2147-2157
        • Costa M.J.
        • Weiss S.W.
        Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome.
        Am J Surg Pathol. 1990; 14: 1126-1132
        • Thway K.
        Angiomatoid fibrous histiocytoma: a review with recent genetic findings.
        Arch Pathol Lab Med. 2008; 132: 273-277
        • Thway K.
        • Nicholson A.G.
        • Wallace W.A.
        • et al.
        Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions.
        Am J Surg Pathol. 2012; 36: 883-888
        • Chen G.
        • Folpe A.L.
        • Colby T.V.
        • et al.
        Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology.
        Mod Pathol. 2011; 24: 1560-1570
        • Dunham C.
        • Hussong J.
        • Seiff M.
        • Pfeifer J.
        • Perry A.
        Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.
        Am J Surg Pathol. 2008; 32: 478-484
        • Ochalski P.G.
        • Edinger J.T.
        • Horowitz M.B.
        • et al.
        Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage.
        J Neurosurg. 2010; 112: 978-982
        • Mangham D.C.
        • Williams A.
        • Lalam R.K.
        • et al.
        Angiomatoid fibrous histiocytoma of bone: a calcifying sclerosing variant mimicking osteosarcoma.
        Am J Surg Pathol. 2010; 34: 279-285
        • Schaefer I.M.
        • Fletcher C.D.
        Myxoid variant of so-called angiomatoid "malignant fibrous histiocytoma": clinicopathologic characterization in a series of 21 cases.
        Am J Surg Pathol. 2014; 38: 816-823
        • Rekhi B.
        • Antonescu C.R.
        • Chen G.
        Angiomatoid fibrous histiocytoma.
        in: WHO Classification of Tumours Editorial Board World Health Organization classification of soft tissue and bone tumours. 5th ed. IARC Press, Lyon2020
        • Antonescu C.R.
        • Dal Cin P.
        • Nafa K.
        • et al.
        EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
        Genes Chromosomes Cancer. 2007; 46: 1051-1060
        • Thway K.
        • Stefanaki K.
        • Papadakis V.
        • Fisher C.
        Metastatic angiomatoid fibrous histiocytoma of the scalp, with EWSR1-CREB1 gene fusions in primary tumor and nodal metastasis.
        Hum Pathol. 2013; 44: 289-293
        • Fanburg-Smith J.C.
        • Miettinen M.
        Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
        Hum Pathol. 1999; 30: 1336-1343
        • Rossi S.
        • Szuhai K.
        • Ijszenga M.
        • et al.
        EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.
        Clin Cancer Res. 2007; 13: 7322-7328
        • Hallor K.H.
        • Mertens F.
        • Jin Y.
        • et al.
        Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma.
        Genes Chromosomes Cancer. 2005; 44: 97-102
        • Hallor K.H.
        • Micci F.
        • Meis-Kindblom J.M.
        • et al.
        Fusion genes in angiomatoid fibrous histiocytoma.
        Cancer Lett. 2007; 251: 158-163
        • Raddaoui E.
        • Donner L.R.
        • Panagopoulos I.
        Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma.
        Diagn Mol Pathol. 2002; 11: 157-162
        • Waters B.L.
        • Panagopoulos I.
        • Allen E.F.
        Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11.
        Cancer Genet Cytogenet. 2000; 121: 109-116
        • Thway K.
        • Fisher C.
        Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status.
        Am J Surg Pathol. 2012; 36: e1-e11
        • Antonescu C.R.
        • Katabi N.
        • Zhang L.
        • et al.
        EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland.
        Genes Chromosomes Cancer. 2011; 50: 559-570
        • Flucke U.
        • Mentzel T.
        • Verdijk M.A.
        • et al.
        EWSR1-ATF1 chimeric transcript in a myoepithelial tumor of soft tissue: a case report.
        Hum Pathol. 2012; 43: 764-768
        • Gru A.A.
        • Becker N.
        • Pfeifer J.D.
        Angiosarcoma of the parotid gland with a t(12;22) translocation creating a EWSR1-ATF1 fusion: a diagnostic dilemma.
        J Clin Pathol. 2013; 66: 452-454
        • Stockman D.L.
        • Miettinen M.
        • Suster S.
        • et al.
        Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract.
        Am J Surg Pathol. 2012; 36: 857-868
        • Zambrano E.
        • Reyes-Mugica M.
        • Franchi A.
        • Rosai J.
        An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator.
        Int J Surg Pathol. 2003; 11: 75-81
        • Shenjere P.
        • Salman W.D.
        • Singh M.
        • et al.
        Intra-abdominal clear-cell sarcoma: a report of 3 cases, including 1 case with unusual morphological features, and review of the literature.
        Int J Surg Pathol. 2012; 20: 378-385
        • Thway K.
        • Nicholson A.G.
        • Lawson K.
        • et al.
        Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity.
        Am J Surg Pathol. 2011; 35: 1722-1732
        • Nicholson A.G.
        • Baandrup U.
        • Florio R.
        • Sheppard M.N.
        • Fisher C.
        Malignant myxoid endobronchial tumour: a report of two cases with a unique histological pattern.
        Histopathology. 1999; 35: 313-318
        • Orrock J.M.
        • Abbott J.J.
        • Gibson L.E.
        • Folpe A.L.
        INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
        Am J Dermatopathol. 2009; 31: 152-156
        • Hornick J.L.
        • Dal Cin P.
        • Fletcher C.D.
        Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
        Am J Surg Pathol. 2009; 33: 542-550
        • Fisher C.
        Epithelioid sarcoma of enzinger.
        Adv Anat Pathol. 2006; 13: 114-121
        • Miettinen M.
        • Fanburg-Smith J.C.
        • Virolainen M.
        • Shmookler B.M.
        • Fetsch J.F.
        Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis.
        Hum Pathol. 1999; 30: 934-942
        • Smith M.E.
        • Brown J.I.
        • Fisher C.
        Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin.
        Histopathology. 1998; 33: 425-431
        • Humble S.D.
        • Prieto V.G.
        • Horenstein M.G.
        Cytokeratin 7 and 20 expression in epithelioid sarcoma.
        J Cutan Pathol. 2003; 30: 242-246
        • Shiratsuchi H.
        • Oshiro Y.
        • Saito T.
        • et al.
        Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
        Int J Surg Pathol. 2001; 9: 37-48
        • Lin L.
        • Hicks D.
        • Xu B.
        • et al.
        Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma.
        Mod Pathol. 2005; 18: 705-709
        • Miettinen M.
        • Wang Z.
        • Sarlomo-Rikala M.
        • et al.
        ERG expression in epithelioid sarcoma: a diagnostic pitfall.
        Am J Surg Pathol. 2013; 37: 1580-1585
        • Smith M.E.
        • Awasthi R.
        • O'Shaughnessy S.
        • Fisher C.
        Evaluation of perineurial differentiation in epithelioid sarcoma.
        Histopathology. 2005; 47: 575-581
        • Guillou L.
        • Wadden C.
        • Coindre J.M.
        • Krausz T.
        • Fletcher C.D.
        Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
        Am J Surg Pathol. 1997; 21: 130-146
        • Hasegawa T.
        • Matsuno Y.
        • Shimoda T.
        • et al.
        Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases.
        Mod Pathol. 2001; 14: 655-663
        • Hollmann T.J.
        • Hornick J.L.
        INI1-deficient tumors: diagnostic features and molecular genetics.
        Am J Surg Pathol. 2011; 35: e47-63
        • Fanburg-Smith J.C.
        • Hengge M.
        • Hengge U.R.
        • Smith Jr., J.S.
        • Miettinen M.
        Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.
        Ann Diagn Pathol. 1998; 2: 351-362
        • Kodet R.
        • Newton Jr., W.A.
        • Sachs N.
        • et al.
        Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study.
        Hum Pathol. 1991; 22: 674-684
        • Laskin W.B.
        • Weiss S.W.
        • Bratthauer G.L.
        Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma).
        Am J Surg Pathol. 1991; 15: 1136-1145
        • Ammerlaan A.C.
        • Ararou A.
        • Houben M.P.
        • et al.
        Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome.
        Br J Cancer. 2008; 98: 474-479
        • Gleason B.C.
        • Fletcher C.D.
        Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases.
        Am J Surg Pathol. 2007; 31: 1813-1824
        • Rekhi B.
        • Sable M.
        • Jambhekar N.A.
        Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues.
        Virchows Arch. 2012; 461: 687-697
        • Antonescu C.R.
        • Zhang L.
        • Chang N.E.
        • et al.
        EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.
        Genes Chromosomes Cancer. 2010; 49: 1114-1124
        • Flucke U.
        • Palmedo G.
        • Blankenhorn N.
        • et al.
        EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases.
        Mod Pathol. 2011; 24: 1444-1450
        • Kurzawa P.
        • Kattapuram S.
        • Hornicek F.J.
        • et al.
        Primary myoepithelioma of bone: a report of 8 cases.
        Am J Surg Pathol. 2013; 37: 960-968
        • Brandal P.
        • Panagopoulos I.
        • Bjerkehagen B.
        • et al.
        Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma.
        Genes Chromosomes Cancer. 2008; 47: 558-564
        • Brandal P.
        • Panagopoulos I.
        • Bjerkehagen B.
        • Heim S.
        t(19;22)(q13;q12) Translocation leading to the novel fusion gene EWSR1-ZNF444 in soft tissue myoepithelial carcinoma.
        Genes Chromosomes Cancer. 2009; 48: 1051-1056
        • Thway K.
        • Bown N.
        • Miah A.
        • Turner R.
        • Fisher C.
        Rhabdoid variant of myoepithelial carcinoma, with EWSR1 rearrangement: expanding the spectrum of EWSR1-rearranged myoepithelial tumors.
        Head Neck Pathol. 2015; 9: 273-279
        • Thway K.
        • Fisher C.
        Myoepithelial tumor of soft tissue: histology and genetics of an evolving entity.
        Adv Anat Pathol. 2014; 21: 411-419
        • Suchak R.
        • Thway K.
        • Zelger B.
        • Fisher C.
        • Calonje E.
        Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
        Am J Surg Pathol. 2011; 35: 60-69
        • Errani C.
        • Zhang L.
        • Sung Y.S.
        • et al.
        A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
        Genes Chromosomes Cancer. 2011; 50: 644-653
        • Antonescu C.R.
        • Le Loarer F.
        • Mosquera J.M.
        • et al.
        Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
        Genes Chromosomes Cancer. 2013; 52: 775-784
        • Hornick J.L.
        • Fletcher C.D.
        Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
        Am J Surg Pathol. 2011; 35: 190-201
        • Billings S.D.
        • Folpe A.L.
        • Weiss S.W.
        Epithelioid Sarcoma-like hemangioendothelioma (pseudomyogenic hemangioendothelioma).
        Am J Surg Pathol. 2011; 35: 1088-1089
        • Billings S.D.
        • Folpe A.L.
        • Weiss S.W.
        Epithelioid sarcoma-like hemangioendothelioma.
        Am J Surg Pathol. 2003; 27: 48-57
        • Mirra J.M.
        • Kessler S.
        • Bhuta S.
        • Eckardt J.
        The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors.
        Cancer. 1992; 69: 1382-1395
        • Amary M.F.
        • O'Donnell P.
        • Berisha F.
        • et al.
        Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases.
        Skeletal Radiol. 2013; 42: 947-957
        • Trombetta D.
        • Magnusson L.
        • von Steyern F.V.
        • et al.
        Translocation t(7;19)(q22;q13)−a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?.
        Cancer Genet. 2011; 204: 211-215
        • Walther C.
        • Tayebwa J.
        • Lilljebjörn H.
        • et al.
        A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
        J Pathol. 2014; 232: 534-540
        • Lin L.
        • Skacel M.
        • Sigel J.E.
        • et al.
        Epithelioid sarcoma: an immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma.
        J Cutan Pathol. 2003; 30: 114-117
        • Hornick J.L.
        • Fletcher C.D.
        Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
        Am J Surg Pathol. 2003; 27: 1183-1196
        • Kilpatrick S.E.
        • Hitchcock M.G.
        • Kraus M.D.
        • Calonje E.
        • Fletcher C.D.
        Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept.
        Am J Surg Pathol. 1997; 21: 13-22
        • Fisher C.
        The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review.
        Histopathology. 2014; 64: 134-150
        • Fisher C.
        • Miettinen M.
        Parachordoma: a clinicopathologic and immunohistochemical study of four cases of an unusual soft tissue neoplasm.
        Ann Diagn Pathol. 1997; 1: 3-10
        • Folpe A.L.
        • Agoff S.N.
        • Willis J.
        • Weiss S.W.
        Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.
        Am J Surg Pathol. 1999; 23: 1059-1067
        • Fisher C.
        Unusual myoid, perivascular, and postradiation lesions, with emphasis on atypical vascular lesion, postradiation cutaneous angiosarcoma, myoepithelial tumors, myopericytoma, and perivascular epithelioid cell tumor.
        Semin Diagn Pathol. 2013; 30: 73-84
        • Le Loarer F.
        • Zhang L.
        • Fletcher C.D.
        • et al.
        Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
        Genes Chromosomes Cancer. 2014; 53: 475-486
        • Huang S.C.
        • Chen H.W.
        • Zhang L.
        • et al.
        Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.
        Genes Chromosomes Cancer. 2015; 54: 267-275
        • Agaram N.P.
        • Chen H.W.
        • Zhang L.
        • et al.
        EWSR1-PBX3: a novel gene fusion in myoepithelial tumors.
        Genes Chromosomes Cancer. 2015; 54: 63-71
        • Bahrami A.
        • Dalton J.D.
        • Krane J.F.
        • Fletcher C.D.
        A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart.
        Genes Chromosomes Cancer. 2012; 51: 140-148
        • Antonescu C.R.
        • Zhang L.
        • Shao S.Y.
        • et al.
        Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.
        Genes Chromosomes Cancer. 2013; 52: 675-682
        • Suurmeijer A.J.H.
        • Dickson B.C.
        • Swanson D.
        • et al.
        A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
        Genes Chromosomes Cancer. 2018; 57: 611-621
        • Davis J.L.
        • Lockwood C.M.
        • Albert C.M.
        • et al.
        Infantile NTRK-associated mesenchymal tumors.
        Pediatr Dev Pathol. 2018 Jan-Feb; 21: 68-78
        • Albert C.M.
        • Davis J.L.
        • Federman N.
        • Casanova M.
        • Laetsch T.W.
        TRK fusion cancers in children: a clinical review and recommendations for screening.
        J Clin Oncol. 2019; 37: 513-524
        • Agaram N.P.
        • Zhang L.
        • Sung Y.S.
        • et al.
        Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors.
        Am J Surg Pathol. 2016; 40: 1407-1416
        • Suurmeijer A.J.
        • Dickson B.C.
        • Swanson D.
        • et al.
        The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
        Genes Chromosomes Cancer. 2019; 58: 739-746
        • Davis J.L.
        • Lockwood C.M.
        • Stohr B.
        • et al.
        Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors.
        Am J Surg Pathol. 2019; 43: 435-445
        • Haller F.
        • Knopf J.
        • Ackermann A.
        • et al.
        Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
        J Pathol. 2016; 238: 700-710
        • Hung Y.P.
        • Fletcher C.D.M.
        • Hornick J.L.
        Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
        Histopathology. 2018; 73: 634-644
        • Hechtman J.F.
        • Benayed R.
        • Hyman D.M.
        • et al.
        Pan-trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions.
        Am J Surg Pathol. 2017; 41: 1547-1551
        • Rudzinski E.R.
        • Lockwood C.M.
        • Stohr B.A.
        • et al.
        Pan-trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors.
        Am J Surg Pathol. 2018; 42: 927-935
        • Cocco E.
        • Scaltriti M.
        • Drilon A.
        NTRK fusion-positive cancers and TRK inhibitor therapy.
        Nat Rev Clin Oncol. 2018; 15: 731-747
        • Di Giannatale A.
        • Frezza A.M.
        • Le Deley M.C.
        • et al.
        Primary cutaneous and subcutaneous Ewing sarcoma.
        Pediatr Blood Cancer. 2015; 62: 1555-1561
        • Ko J.S.
        • Marusic Z.
        • Azzato E.M.
        • et al.
        Superficial sarcomas with CIC rearrangement are aggressive neoplasms: a series of eight cases.
        J Cutan Pathol. 2020; 47: 509-516